
PeproMene Bio
Operator of a biotechnology company intended to develop novel immune-oncology therapies. The company offers services including developing leukemia-specific immune cell therapy based on novel antibodie...
Valuation
$0
Share Price
N/A
Total Raised
$50.2M
Last Round
N/A